Personal tools

FF:0000513: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 1: Line 1:
{{F5terms
{{F5terms
|id=FF:0000513
|alt_id=
|name=J2E erythroblastic leukemia line 48hr after treatment with erythropoietin
|namespace=FANTOM5
|def=
|xref=
|is_a=EFO:0001746;;FF:0000337;;FF:0000350;;FF:0000375;;FF:0000403
|synonym=
|comment=
|comment=
|alt_id=
|disjoint_from=
|union_of=
|created_by=
|created_by=
|obo_creation_date=
|def=
|subset=
|derives_from=
|derives_from=
|develops_from=
|develops_from=
|disjoint_from=
|has_quality=
|has_quality=
|id=FF:0000513
|is_a=EFO:0001746 ;;FF:0000337 ;;FF:0000350 ;;FF:0000375 ;;FF:0000403
|is_obsolete=
|located_in=
|located_in=
|name=J2E erythroblastic leukemia line 48hr after treatment with erythropoietin
|namespace=FANTOM5
|obo_creation_date=
|part_of=
|part_of=
|preceded_by=
|property_value=
|property_value=
|is_obsolete=
|subset=
|preceded_by=
|synonym=
|union_of=
|xref=
}}
}}

Revision as of 10:40, 12 September 2014

outline

  • id: FF:0000513
  • name: J2E erythroblastic leukemia line 48hr after treatment with erythropoietin
  • namespace: FANTOM5
  • CAGEd oPOSSUM: NA

Ontology association

Parents

is_a:EFO:0001746(development or differentiation design),FF:0000337(erythropoietin treatment sample),FF:0000350(experimentally modified sample),FF:0000375(48 hr sample),FF:0000403(mouse J2E erythroblastic leukemia cell line sample)

Children

is a:FF:13078-140A9 (J2E erythroblastic leukemia response to erythropoietin),FF:13144-140I3 (J2E erythroblastic leukemia response to erythropoietin),FF:13210-141G6 (J2E erythroblastic leukemia response to erythropoietin)

FF Samples

Mouse

  • 13078-140A9 (J2E erythroblastic leukemia response to erythropoietin)
  • 13144-140I3 (J2E erythroblastic leukemia response to erythropoietin)
  • 13210-141G6 (J2E erythroblastic leukemia response to erythropoietin)